Page last updated: 2024-08-17

medroxyprogesterone acetate and Chlamydia Infections

medroxyprogesterone acetate has been researched along with Chlamydia Infections in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19901 (7.69)18.7374
1990's2 (15.38)18.2507
2000's7 (53.85)29.6817
2010's2 (15.38)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Ahmed, K; Baeten, JM; Batting, J; Beksinska, M; Deese, J; Donnell, D; Edward, VA; Lind, M; Louw, CE; Mastro, TD; Morrison, C; Mugo, NR; Nanda, K; Onono, M; Palanee-Phillips, T; Philip, N; Rees, H; Smit, JA1
Armitage, CW; Beagley, KW; O'Meara, CP1
Carmichael, JR; de la Maza, LM; Pal, S; Tifrea, D1
CastaƱo, PM; Stuart, GS1
Baeten, JM; Chohan, V; Hassan, W; Kreiss, J; Lavreys, L; Mandaliya, K; McClelland, RS; Ndinya-Achola, J; Overbaugh, J1
MacLean, R1
Bahamondes, L; Caraway, J; Condon, S; El-Shafei, M; Feldblum, PJ; Morales, E; Quan Ha, D; Wevill, S1
Livengood, CH; Soper, DE; Thurman, AR1
Amortegui, AJ; Blander, SJ1
Grimes, DA1
Farmer, M; Gaydos, C; Graham, NM; Jacobson, DL; Peralta, L; Zenilman, J1
Baeten, JM; Bwayo, JJ; Chohan, B; Kreiss, JK; Lavreys, L; Mandaliya, K; Martin, HL; Ndinya-Achola, JO; Nyange, PM; Richardson, BA1
Insler, V; Kleinman, D; Sarov, I1

Reviews

1 review(s) available for medroxyprogesterone acetate and Chlamydia Infections

ArticleYear
Sexually transmitted infections and contraceptives: selective issues.
    Obstetrics and gynecology clinics of North America, 2003, Volume: 30, Issue:4

    Topics: Chlamydia Infections; Condoms; Contraception; Contraceptive Devices, Female; Contraceptives, Oral; Female; Gonorrhea; HIV Infections; Humans; Intrauterine Devices; Male; Medroxyprogesterone Acetate; Papillomaviridae; Pelvic Inflammatory Disease; Sexually Transmitted Diseases

2003

Trials

2 trial(s) available for medroxyprogesterone acetate and Chlamydia Infections

ArticleYear
Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant.
    Sexually transmitted infections, 2021, Volume: 97, Issue:4

    Topics: Adolescent; Adult; Africa; Chlamydia Infections; Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Disease Susceptibility; Drug Implants; Female; Gonorrhea; Humans; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate; Prevalence; Young Adult

2021
Randomized assignment to copper IUD or depot-medroxyprogesterone acetate: feasibility of enrollment, continuation and disease ascertainment.
    Contraception, 2005, Volume: 72, Issue:3

    Topics: Adolescent; Adult; Chlamydia Infections; Contraceptive Agents, Female; Feasibility Studies; Female; Gonorrhea; Humans; Intrauterine Devices, Copper; Medroxyprogesterone Acetate; Pelvic Inflammatory Disease; Pilot Projects

2005

Other Studies

10 other study(ies) available for medroxyprogesterone acetate and Chlamydia Infections

ArticleYear
Chlamydial infection enhances expression of the polymeric immunoglobulin receptor (pIgR) and transcytosis of IgA.
    American journal of reproductive immunology (New York, N.Y. : 1989), 2017, Volume: 77, Issue:1

    Topics: Animals; Chlamydia; Chlamydia Infections; Contraceptive Agents; Epithelium; Female; Gonadal Steroid Hormones; Humans; Immunoglobulin A; Male; Medroxyprogesterone Acetate; Menstrual Cycle; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Receptors, Polymeric Immunoglobulin; Transcytosis; Uterus

2017
Differences in infectivity and induction of infertility: a comparative study of Chlamydia trachomatis strains in the murine model.
    Microbes and infection, 2013, Volume: 15, Issue:3

    Topics: Animals; Chlamydia Infections; Chlamydia trachomatis; Disease Models, Animal; Female; Fertility; Infertility; Male; Medroxyprogesterone Acetate; Mice; Mice, Inbred C3H; Statistics, Nonparametric; Vagina

2013
Hormonal contraception and risk of cervical infections among HIV-1-seropositive Kenyan women.
    AIDS (London, England), 2004, Nov-05, Volume: 18, Issue:16

    Topics: Adult; Chlamydia Infections; Contraceptives, Oral, Hormonal; Developing Countries; Female; Follow-Up Studies; HIV Seropositivity; HIV-1; Humans; Injections, Intravenous; Kenya; Medroxyprogesterone Acetate; Proportional Hazards Models; Prospective Studies; Risk; Sex Work; Sexually Transmitted Diseases; Uterine Cervicitis

2004
Injectable use may increase women's odds of getting chlamydia or gonorrhea.
    International family planning perspectives, 2005, Volume: 31, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Baltimore; Cervix Uteri; Chlamydia Infections; Contraception; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Female; Gonorrhea; Humans; Medroxyprogesterone Acetate; Risk Factors; Sexually Transmitted Diseases; Uterine Cervical Diseases

2005
Chronic endometritis in DMPA users and Chlamydia trachomatis endometritis.
    Contraception, 2007, Volume: 76, Issue:1

    Topics: Biopsy; Chlamydia Infections; Chlamydia trachomatis; Chronic Disease; Contraceptive Agents, Female; Cross-Sectional Studies; Delayed-Action Preparations; DNA, Bacterial; Endometritis; Female; Humans; Medroxyprogesterone Acetate; Polymerase Chain Reaction; Prevalence; South Carolina

2007
Mice immunized with a chlamydial extract have no increase in early protective immunity despite increased inflammation following genital infection by the mouse pneumonitis agent of Chlamydia trachomatis.
    Infection and immunity, 1994, Volume: 62, Issue:9

    Topics: Animals; Chlamydia Infections; Chlamydia trachomatis; Female; Genital Diseases, Female; Hypersensitivity, Delayed; Immunization; Inflammation; Lymphocyte Activation; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C

1994
A 17-year-old mother seeking contraception.
    JAMA, 1996, Oct-09, Volume: 276, Issue:14

    Topics: Adolescent; Chlamydia Infections; Contraception; Contraceptive Agents, Female; Contraceptives, Oral; Decision Making; Family Planning Services; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Patient Compliance; Patient Education as Topic; Pregnancy; Pregnancy in Adolescence; Recurrence; Sexually Transmitted Diseases; Single Parent

1996
Relationship of hormonal contraception and cervical ectopy as measured by computerized planimetry to chlamydial infection in adolescents.
    Sexually transmitted diseases, 2000, Volume: 27, Issue:6

    Topics: Adolescent; Adolescent Behavior; Adult; Baltimore; Cervix Uteri; Child; Chlamydia Infections; Chlamydia trachomatis; Contraceptives, Oral, Combined; Cross-Sectional Studies; Female; Humans; Medroxyprogesterone Acetate; Multivariate Analysis; Prevalence; Risk Factors; Surveys and Questionnaires; Uterine Cervical Diseases

2000
Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study.
    American journal of obstetrics and gynecology, 2001, Volume: 185, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Candidiasis, Vulvovaginal; Chlamydia Infections; Cohort Studies; Condoms; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Female; Gonorrhea; Humans; Kenya; Medroxyprogesterone Acetate; Middle Aged; Pelvic Inflammatory Disease; Prospective Studies; Risk Factors; Sex Work; Sexual Behavior; Sexually Transmitted Diseases; Trichomonas Vaginitis; Vaginosis, Bacterial

2001
The effects of contraceptive hormones on the replication of Chlamydia trachomatis in human endometrial cells.
    Contraception, 1987, Volume: 35, Issue:6

    Topics: Chlamydia Infections; Chlamydia trachomatis; Endometrium; Ethinyl Estradiol; Female; Humans; In Vitro Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Mestranol; Time Factors

1987